A federal jury found two former senior executives from Acclarent, a Johnson & Johnson division, guilty of illegally marketing a medical device, according to a story in The Wall Street Journal.
Federal prosecutors said that beginning in 2006 or earlier, former Acclarent Chief Executive William Facteau and former Vice President of Sales Patrick Fabian promoted Acclarent's Relieva Stratus Microflow Spacer device to deliver steroid medications to patients' sinuses, though it was only approved by the FDA for keeping sinuses open. The jury convicted them on 10 misdemeanor counts of introducing adulterated and misbranded medical devices into interstate commerce, but acquitted them on 14 felony counts of conspiracy, wire fraud and felony adulteration and misbranding charges.
Defense attorneys for both men said they planned to appeal the convictions.
Read the WSJ article